These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 427755
41. Aflatoxins as a cause of hepatocellular carcinoma. Kew MC. J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988 [Abstract] [Full Text] [Related]
42. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Essigmann JM, Croy RG, Bennett RA, Wogan GN. Drug Metab Rev; 1982 Sep; 13(4):581-602. PubMed ID: 6813091 [No Abstract] [Full Text] [Related]
43. Alteration of the aflatoxin cyclopentenone ring to a delta-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides. Raney KD, Gopalakrishnan S, Byrd S, Stone MP, Harris TM. Chem Res Toxicol; 1990 Sep; 3(3):254-61. PubMed ID: 2131838 [Abstract] [Full Text] [Related]
44. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Croy RG, Essigmann JM, Reinhold VN, Wogan GN. Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1745-9. PubMed ID: 273905 [Abstract] [Full Text] [Related]
45. Metabolic activation of 6-nitrochrysene in explants of human bronchus and in isolated rat hepatocytes. Delclos KB, el-Bayoumy K, Casciano DA, Walker RP, Kadlubar FF, Hecht SS, Shivapurkar N, Mandal S, Stoner GD. Cancer Res; 1989 Jun 01; 49(11):2909-13. PubMed ID: 2720650 [Abstract] [Full Text] [Related]
46. Intercellular variation in levels of adducts of aflatoxin B1 and G1 in DNA from rat tissues: a quantitative immunocytochemical study. Wild CP, Montesano R, Van Benthem J, Scherer E, Den Engelse L. J Cancer Res Clin Oncol; 1990 Jun 01; 116(2):134-40. PubMed ID: 2108967 [Abstract] [Full Text] [Related]
47. Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Mandal S, Ahuja A, Shivapurkar NM, Cheng SJ, Groopman JD, Stoner GD. Carcinogenesis; 1987 Nov 01; 8(11):1651-6. PubMed ID: 3117405 [Abstract] [Full Text] [Related]
48. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium. Stark AA, Essigmann JM, Demain AL, Skopek TR, Wogan GN. Proc Natl Acad Sci U S A; 1979 Mar 01; 76(3):1343-7. PubMed ID: 375236 [Abstract] [Full Text] [Related]
49. Metabolism of chemical carcinogens by cultured human and rat bladder epithelial cells. Autrup H, Grafstrom RC, Christensen B, Kieler J. Carcinogenesis; 1981 Mar 01; 2(8):763-8. PubMed ID: 6269774 [Abstract] [Full Text] [Related]
50. Interaction of aflatoxin B2 with rat liver DNA and histones in vivo. Groopman JD, Fowler KW, Busby WF, Wogan GN. Carcinogenesis; 1981 Mar 01; 2(12):1371-3. PubMed ID: 7326836 [Abstract] [Full Text] [Related]
51. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase. Chetsanga CJ, Frenette GP. Carcinogenesis; 1983 Aug 01; 4(8):997-1000. PubMed ID: 6409445 [Abstract] [Full Text] [Related]
52. Carcinogen-nucleic acid interactions: equilibrium binding studies of aflatoxins B1 and B2 with DNA and the oligodeoxynucleotide d(ATGCAT)2. Stone MP, Gopalakrishnan S, Harris TM, Graves DE. J Biomol Struct Dyn; 1988 Apr 01; 5(5):1025-41. PubMed ID: 3152158 [Abstract] [Full Text] [Related]
53. Metabolic activation of mycotoxins by animals and humans: an overview. Shank RC. J Toxicol Environ Health; 1977 Jul 01; 2(6):1229-44. PubMed ID: 328914 [Abstract] [Full Text] [Related]
54. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Groopman JD, Donahue PR, Zhu JQ, Chen JS, Wogan GN. Proc Natl Acad Sci U S A; 1985 Oct 01; 82(19):6492-6. PubMed ID: 3931076 [Abstract] [Full Text] [Related]
55. Metabolism and DNA binding of benzo[a]pyrene in cultured human bladder and bronchus. Stoner GD, Daniel FB, Schenck KM, Schut HA, Goldblatt PJ, Sandwisch DW. Carcinogenesis; 1982 Oct 01; 3(2):195-201. PubMed ID: 6279329 [Abstract] [Full Text] [Related]
56. Properties of aflatoxin-DNA adducts formed by photoactivation and characterization of the major photoadduct as aflatoxin-N7-guanine. Shaulsky G, Johnson RL, Shockcor JP, Taylor LC, Stark AA. Carcinogenesis; 1990 Apr 01; 11(4):519-27. PubMed ID: 2108817 [Abstract] [Full Text] [Related]
57. Synthesis and Characterization of 15N5-Labeled Aflatoxin B1-Formamidopyrimidines and Aflatoxin B1-N7-Guanine from a Partial Double-Stranded Oligodeoxynucleotide as Internal Standards for Mass Spectrometric Measurements. Jaruga P, Tomar R, Kant M, Vartanian V, Sexton B, Rizzo CJ, Turesky RJ, Stone MP, Lloyd RS, Dizdaroglu M. ACS Omega; 2023 Apr 25; 8(16):14841-14854. PubMed ID: 37125130 [Abstract] [Full Text] [Related]
58. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. Raney KD, Shimada T, Kim DH, Groopman JD, Harris TM, Guengerich FP. Chem Res Toxicol; 1992 Apr 25; 5(2):202-10. PubMed ID: 1643250 [Abstract] [Full Text] [Related]
59. Comparison of aflatoxin B1 and aflatoxin G1 binding to cellular macromolecules in vitro, in vivo and after peracid oxidation; characterisation of the major nucleic acid adducts. Garner RC, Martin CN, Smith JR, Coles BF, Tolson MR. Chem Biol Interact; 1979 Jun 25; 26(1):57-73. PubMed ID: 466744 [Abstract] [Full Text] [Related]